Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_assertion type Assertion NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_head.
- NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_assertion description "[These data indicate simultaneous inhibition of PI3K-mTOR and MEK signaling is an effective strategy for treating EGFR mutant lung cancers, including those with acquired resistance to EGFR TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_provenance.
- NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_assertion evidence source_evidence_literature NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_provenance.
- NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_assertion SIO_000772 19850869 NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_provenance.
- NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_assertion wasDerivedFrom befree-2016 NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_provenance.
- NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_assertion wasGeneratedBy ECO_0000203 NP771181.RAtnuVKtCIBCgQM7Tu8CAsx8iaiPgCGuAp_5U_xIMyc3I130_provenance.